:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/FFHCIAEHJ5ETDD55L2WXUEWA6Y.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/d1vhqlrjc8h82r.cloudfront.net/09-18-2021/t_647bc2f96a254ec3a88a13338776b1b1_name_image.jpg)
US panel backs COVID-19 boosters only for seniors, high-risk patients
Read full article: US panel backs COVID-19 boosters only for seniors, high-risk patientsAn influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it endorsed the extra doses for those who are 65 or older or run a high risk of severe disease.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/d1vhqlrjc8h82r.cloudfront.net/02-27-2021/t_5f8c82e64a9a422ea05c217bae90cbbf_name_image.jpg)
US panel endorses single-shot COVID-19 vaccine from J&J
Read full article: US panel endorses single-shot COVID-19 vaccine from J&JWASHINGTON – U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, putting the nation on the cusp of adding an easier-to-use option to fight the pandemic. One challenge in rolling out the new vaccine will be explaining how protective the J&J shot is after the astounding success of the first U.S. vaccines. One dose of the J&J vaccine was 85% protective against the most severe COVID-19. AdImportantly, the FDA reported this week that, just like its predecessors, the J&J shot offers strong protection against the worst outcomes, hospitalization and death. On Sunday, a CDC panel is expected to meet to recommend how to best prioritize use of the J&J vaccine.